ストックスクリーナーアプリを入手
1.18
1.72%
0.02
前日終値:
$1.16
開ける：
$1.1499
24時間の取引高:
89,867
Relative Volume:
0.68
時価総額：
$4.49M
収益：
-
当期純損益:
$-7.04M
株価収益率:
-0.2695
EPS:
-4.3784
ネットキャッシュフロー:
$-6.17M
1週間 パフォーマンス:
+1.72%
1か月 パフォーマンス:
+1.72%
6か月 パフォーマンス:
-50.63%
1年 パフォーマンス:
-61.31%
1日の値動き範囲:
$1.1309
$1.23
1週間の範囲:
$1.0827
$1.23
52週間の値動き範囲:
$0.84
$3.5996
Alzamend Neuro Inc Stock (ALZN) Company Profile
名前
Alzamend Neuro Inc
セクター
電話
844-722-6333
住所
480 PEACHTREE ROAD NE, SECOND FLOOR, ATLANTA
Compare ALZN vs VRTX, REGN, ARGX, ALNY, RVMD
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ALZN
Alzamend Neuro Inc
|
1.18 | 4.49M | 0 | -7.04M | -6.17M | -4.3784 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Alzamend Neuro Inc Stock (ALZN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-01 | 開始されました | Ascendiant Capital Markets | Buy |
Alzamend Neuro Inc (ALZN) 最新ニュース
Price to sales forward of Alzamend Neuro, Inc. – BOATS:ALZN - TradingView
ALZN Q2 2026 Earnings: Narrower-than-expected loss sparks positive market reactionFiscal Year Earnings - dars.gov.et
ALZN Q2 2026 Earnings: EPS Beat by 70% but No Revenue – Stock Jumps on SurpriseGuidance Upgrade Report - dars.gov.et
$Alzamend Neuro (ALZN.US)$ it be like that - Moomoo
12 Health Care Stocks Moving In Tuesday's After-Market SessionAlzamend Neuro (NASDAQ:ALZN), Vivos Ther - Benzinga
ALZN Q4'25 Earnings: EPS estimate is (0.67) USD - TradingView
Alzamend Neuro | DEF 14A: Definitive information statements - Moomoo
Alzamend Neuro, Inc. Actuals & Estimates (NASDAQ:ALZN) - TradingView
Alzamend Neuro, Inc. Actuals & Estimates (BOATS:ALZN) - TradingView
Price to book forward of Alzamend Neuro, Inc. – NASDAQ:ALZN - TradingView
ALZN Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Alzamend Neuro, Inc. – NASDAQ:ALZN - TradingView
Price to sales forward of Alzamend Neuro, Inc. – NASDAQ:ALZN - TradingView
ALZN Q4'25 Earnings: revenue estimate is 0 USD - TradingView
ALZN Q1 2026 Earnings: Narrower-Than-Expected Loss SurprisesFiscal Year Earnings - dars.gov.et
Alzamend Neuro Inc (ALZN) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Alzamend Neuro Inc (ALZN) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Alzamend Neuro Inc (ALZN) Valuation: PE, PB & Fair Value Analysis - TradingKey
Alzamend Neuro Inc (ALZN) Institutional Confidence - TradingKey
Alzamend Neuro Inc (ALZN) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Alzamend Neuro Inc (ALZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Alzamend Neuro Inc (ALZN) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Alzamend Neuro Inc (ALZN) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
ALZN Q1 2026 Earnings: Smaller-than-Expected Loss Drives Shares HigherEarnings Manipulation Risk - newsline.com
Alzamend Neuro, Inc. Financial Disclosures & SEC Filings - TradingView
ALZN Q1 2026 Earnings: Narrower-than-Expected Loss Delivers 70% Positive SurpriseEarnings Revision Downgrade - newsline.com
Alzamend Neuro Shares Dip With AL001 Trial in Focus, Cash Concerns Linger - Bez Kabli
ALZN Q1 2026 Earnings: Significant EPS Beat Driven by Narrower-than-Expected LossOne-Time Loss Impact - newsline.com
Alzamend Neuro, Inc.Common Stock (NQ: ALZN - FinancialContent
Alzamend Neuro (ALZN) Gains 3.48% as Positive Momentum BuildsCash Secured Put - newsline.com
ALZN Q1 2026 Earnings: Narrower-Than-Expected Loss Highlights Cost Management Amid Pre-Revenue PhaseSaaS Earnings Trends - The Legal Advocate
Alzamend Neuro Inc. (ALZN) Stalls Near Support: Consolidation or Caution for This Alzheimer’s Play?Momentum Factor - thelegaladvocate.com
ALZNAlzamend Neuro Inc Stock Price and Quote - Finviz
Alzamend Neuro Inc. (ALZN) Q1 2026 Earnings: Narrower-than-Expected Loss as Early-Stage Biotech Continues R&D FocusEarnings Quality Score - newsline.com
ALZN Q1 2026 Earnings: Narrowing Losses Beat Estimates by 70%EBITDA Estimate Trend - newsline.com
ALZN Q1 2026 Earnings: EPS Surpasses Estimates by Over 70%, Stock DeclinesEarnings Season Preview - The Legal Advocate
ALZN Stock Price, Quote & Chart | ALZAMEND NEURO INC (NASDAQ:ALZN) - ChartMill
TradingKey - TradingKey
How Alzamend (ALZN) handles its debt maturity schedule | Q1 2026: Earnings Beat EstimatesTop Analyst Buy Signals - newser.com
Alzamend Neuro Inc. (ALZN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Alzamend Neuro (ALZN) price target decreased by 10.71% to 25.50 - MSN
Alzamend (ALZN) Stock Swing Trade Setup (On the Radar) 2026-04-20Sector Rotation - Cổng thông tin điện tử tỉnh Lào Cai
Alzamend Neuro, Inc. 8-K Filing Details, NASDAQ Listing, and Corporate Information (April 17, 2026) - Minichart
Alzamend Neuro Shareholders Approve Governance and Capital Measures - The Globe and Mail
Shareholders of Alzamend Neuro (ALZN) approve board slate, plans and reverse split - Stock Titan
Director Milton Ault adds Alzamend Neuro (ALZN) shares in open-market buy - Stock Titan
CEO Moves: How sensitive is Alzamend Neuro Inc to inflationEarnings Overview Report & Smart Investment Allocation Tips - baoquankhu1.vn
Form PRE 14AOther preliminary proxy statements - ADVFN
Can Alzamend Neuro Inc disrupt its industryEarnings Growth Summary & Weekly High Conviction Trade Ideas - baoquankhu1.vn
Aug Sectors: What is the dividend yield of Alzamend Neuro IncQuarterly Profit Review & Long-Term Safe Return Strategies - baoquankhu1.vn
Analysts Offer Insights on Healthcare Companies: Neurogene (NGNE), Alzamend Neuro (ALZN) and Cardiol Therapeutics (CRDL) - The Globe and Mail
Alzamend Neuro Inc (ALZN) 財務データ
収益
当期純利益
現金流量
EPS
Alzamend Neuro Inc (ALZN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| AULT MILTON C III | Director |
Dec 23 '25 |
Sale |
2.07 |
1,851 |
3,825 |
0 |
| Horne William B. | Director |
Dec 19 '25 |
Sale |
2.12 |
3,333 |
7,059 |
0 |
| McGrath Lynne Fahey | Director |
Oct 23 '25 |
Sale |
2.29 |
30 |
69 |
25 |
| AULT MILTON C III | Director |
Oct 08 '25 |
Sale |
2.44 |
101,394 |
247,158 |
28,657 |
| AULT MILTON C III | Director |
Oct 09 '25 |
Sale |
2.32 |
20,397 |
47,390 |
8,260 |
| AULT MILTON C III | Director |
Oct 06 '25 |
Sale |
2.45 |
82,033 |
201,268 |
26,227 |
| AULT MILTON C III | Director |
Oct 07 '25 |
Sale |
2.49 |
57,379 |
142,954 |
68,848 |
| AULT MILTON C III | Director |
Oct 03 '25 |
Sale |
2.44 |
65,903 |
160,889 |
8,260 |
| AULT MILTON C III | Director |
Oct 01 '25 |
Sale |
2.35 |
36,777 |
86,378 |
94,849 |
| AULT MILTON C III | Director |
Oct 02 '25 |
Sale |
2.39 |
20,686 |
49,522 |
74,163 |
2.64%
大文字化:
|
ボリューム (24 時間):